Vascular Dysfunction and Antiangiogenic Therapy

NCT02161978 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 93

Last updated 2019-11-06

No results posted yet for this study

Summary

project is a pilot prospective, longitudinal, before-after, open label multicentric study.

Conditions

  • Solid Tumor
  • Tumor Angiogenesis
  • Endothelial Dysfunction
  • CML (Chronic Myelogenous Leukemia)

Sponsors & Collaborators

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • Samir HENNI, MD · University hospital, Angers, FRANCE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-09
Primary Completion
2018-12-12
Completion
2018-12-12

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02161978 on ClinicalTrials.gov